Is Science or Hype Driving the Gene Therapy Investment "Bubble"?

Gene therapy is a hot topic on Wall Street, with investors ready to bank on its future success. But could this recent investment bubble--$209 million since April 2013--be a repeat of the 1990s, in which a similar surge in investments in gene therapy companies came crashing down when the clinical results could not support the hype?

Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...